A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Trial details
- Registry ID
- NCT06445023
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as CDX-0159
| No regulatory events match this view.This does not mean no FDA events have occurred. |